Literature DB >> 1899105

Anti-CD4 mediates clonal anergy during transplantation tolerance induction.

S E Alters1, J A Shizuru, J Ackerman, D Grossman, K B Seydel, C G Fathman.   

Abstract

Depletion of CD4+ cells using anti-CD4 monoclonal antibodies leads to allograft tolerance. Here we show that anti-CD4-mediated tolerance to pancreatic islets of Langerhans transplanted from an A/J (IEk) donor to a diabetic C57B1/6 (B6) (IE-) recipient occurs in the absence of clonal deletion of the potentially IE-reactive V beta 11+ T cells. Instead, a state of clonal anergy is induced in both the CD4+V beta 11+ and CD8+V beta 11+ T cell subsets. This clonal anergy can be partially overcome in vitro by the addition of recombinant interleukin 2.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899105      PMCID: PMC2118801          DOI: 10.1084/jem.173.2.491

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Comparison of rat and rat-mouse chimeric anti-murine CD4 antibodies in vitro. Chimeric antibodies lyse low-density CD4+ cells.

Authors:  S E Alters; L Steinman; V T Oi
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

2.  A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product.

Authors:  J W Kappler; T Wade; J White; E Kushnir; M Blackman; J Bill; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

3.  Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Authors:  O Leo; M Foo; D H Sachs; L E Samelson; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

4.  T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E.

Authors:  L C Burkly; D Lo; O Kanagawa; R L Brinster; R A Flavell
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

5.  Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones.

Authors:  M K Jenkins; D M Pardoll; J Mizuguchi; T M Chused; R H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Islet allograft survival after a single course of treatment of recipient with antibody to L3T4.

Authors:  J A Shizuru; A K Gregory; C T Chao; C G Fathman
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

7.  Mechanisms of anti-CD4-mediated depletion and immunotherapy. A study using a set of chimeric anti-CD4 antibodies.

Authors:  S E Alters; K Sakai; L Steinman; V T Oi
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

8.  The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells.

Authors:  J Bill; O Kanagawa; D L Woodland; E Palmer
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

9.  Induction of classical transplantation tolerance in the adult.

Authors:  S X Qin; S Cobbold; R Benjamin; H Waldmann
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Recirculating, suppressor T cells in transplantation tolerance.

Authors:  S Dorsch; R Roser
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  [Immunologic tolerance after experimental liver transplantation].

Authors:  M Knoop; U Neumann; P Neuhaus
Journal:  Langenbecks Arch Chir       Date:  1995

Review 3.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

4.  T-cell receptor V beta repertoire of L3T4+ regulatory T cells in anti-L3T4 antibody-induced tolerant NOD mice.

Authors:  A Sakamoto; M Furukawa; I Iwamoto; T Koike; H Tomioka; T Sumida
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

5.  Analysis of the basis of resistance and susceptibility of CD4+ T cells to human immunodeficiency virus (HIV)-gp120 induced anergy.

Authors:  A Faith; R E O'Hehir; M Malkovsky; J R Lamb
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

6.  T cell epitopes of the major fraction of rye grass Lolium perenne (Lol p I) defined using overlapping peptides in vitro and in vivo. I. Isoallergen clone1A.

Authors:  G A Bungy Poor Fard; Y Latchman; S Rodda; M Geysen; I Roitt; J Brostoff
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

7.  Short-term administration of anti-L3T4 MoAb prevents diabetes in NOD mice.

Authors:  K Kurasawa; A Sakamoto; T Maeda; T Sumida; I Ito; H Tomioka; S Yoshida; T Koike
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

8.  Alloreactive (CD4-Independent) CD8+ T cells jeopardize long-term survival of intrahepatic islet allografts.

Authors:  K E Lunsford; K Jayanshankar; A M Eiring; P H Horne; M A Koester; D Gao; G L Bumgardner
Journal:  Am J Transplant       Date:  2008-06       Impact factor: 8.086

9.  CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice.

Authors:  Zhidan Xiang; Lian-Li Ma; Santhakumar Manicassamy; Balaji B Ganesh; Phillip Williams; Ravi Chari; Anita Chong; Deng-Ping Yin
Journal:  Transplantation       Date:  2008-04-27       Impact factor: 4.939

10.  Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.

Authors:  Y Matsumoto; M Tsuchida; H Hanawa; T Abo
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.